[NEU] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[NEU] Neuren Pharmaceuticals Limited
Announcement Date
29-Dec-2023
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 85,270.11%
Quarter Report
NEU's Result
NEU's Financial Summary
View:
Show?
Annual Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 213,243 231,925 14,553 3,197 717 495 13,990 57.39%
PBT 182,940 205,140 -680 -10,991 -9,910 -11,311 3,073 97.47%
Tax 40,897 48,059 -864 -3,197 -717 -495 0 -
NP 142,043 157,081 184 -7,794 -9,193 -10,816 3,073 89.33%
Tax Rate -22.36% -23.43% - - - - 0.00% -
Total Cost 71,200 74,844 14,369 10,991 9,910 11,311 10,917 36.64%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin 66.61 67.73 1.26 -243.79 -1,282.15 -2,185.05 21.97 20.28%
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS 1.09 1.24 0.00 -0.07 -0.09 -0.11 0.03 81.89%
EPS Diluted 1.09 1.20 0.00 -0.07 -0.09 -0.11 0.03 81.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.